CPI-17 Antibodies

Santa Cruz Biotechnology features a diverse variety of CPI-17 monoclonal antibodies for advanced research in cellular signaling. CPI-17 Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CPI-17, or protein kinase C-potentiated inhibitory protein of 17 kDa, plays a crucial role in regulating smooth muscle contraction and is involved in various signaling pathways. The significance of CPI-17 extends to cardiovascular health and muscle physiology, making it an important target for understanding disease mechanisms and therapeutic interventions. Research has shown that CPI-17 functions as a key mediator in cellular processes related to muscle tone regulation and vascular function. Understanding CPI-17's role in these biological processes can provide insights into potential therapeutic strategies for various cardiovascular and muscle-related conditions. Investigating CPI-17's molecular mechanisms and interactions helps advance our knowledge of cellular signaling networks and their impact on human health. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to conduct precise investigations that contribute to advancing scientific understanding of cellular signaling pathways and their therapeutic applications.